Abbott Laboratories (NYSE:ABT)
| 79.35 Delayed Data As of Mar 30 |  +0.01 / +0.01%Today’s Change | 61.61 Today|||52-Week Range 92.45 | -8.65% Year-to-Date |
Latest ABT News | Press Releases
Today’s Trading
| Previous close | 79.34 |
| Today’s open | 77.00 |
| Day’s range | 78.50 - 84.40 |
| Volume | 56,791 |
| Average volume (3 months) | 7,006,232 |
| Market cap | $131.8B |
Data as of 7:59pm ET, 03/30/2020
Growth & Valuation
| Earnings growth (last year) | +54.92% |
| Earnings growth (this year) | +9.40% |
| Earnings growth (next 5 years) | +8.57% |
| Revenue growth (last year) | +4.34% |
| P/E ratio | 38.5 |
| Price/Sales | 4.85 |
| Price/Book | 4.24 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| BDXBecton Dickinson and... | +0.22 | +0.10% |
| BSXBoston Scientific Co... | -0.03 | -0.09% |
| BAXBaxter International... | -0.01 | -0.01% |
| DXCMDexCom Inc | +15.04 | +5.72% |
Data as of 7:19pm ET, 03/30/2020
Financials
| Next reporting date | April 16, 2020 |
| EPS forecast (this quarter) | $0.66 |
| Annual revenue (last year) | $31.9B |
| Annual profit (last year) | $3.7B |
| Net profit margin | 11.49% |
Profile
Sector Health Technology |
Industry Medical Specialties |
No executives to display |
Corporate headquarters Abbott Park, Illinois |
Forecasts
